PACB compared with A: revenue, margins and what each company keeps, and the suppliers and customers both name

PACBPacific Biosciences of California, Inc.

Mkt capRevenueRevenue

AAgilent Technologies, Inc.

Mkt capRevenueRevenue

Compare

PACBPacific Biosciences of California, Inc.

AAgilent Technologies, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PACB

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±25.8%▼−4.71%×0.18

Q2 FY26±37.4%▼−10.38%×0.28

Q1 FY26±12.1%▼−14.55%×1.21

Feb 13 '26±16.5%▼−7.07%×0.43

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.9%▲+1.68%×0.22

Q2 FY26±7.7%▲+16.87%×2.19

= impliedPACB realized, solidA realized, hatchedOne scale, both sides: full bar = 38%× = |realized| ÷ impliedSource: market data

Q1 FY26

±6.4%

▼−3.01%

×0.47

Nov 25 '25±6.5%▲+2.34%×0.35

PACBPacific Biosciences of California, Inc.

2.30▼−5.47%

Mkt cap$792.6MRevenue$41MQ3 FY26Revenue$160MFY25

AAgilent Technologies, Inc.

173.96▲+1.27%

Regular sessionNov 6 '26

Mkt cap$49.9BRevenue$1.9BQ3 FY26Revenue$6.9BFY25

Compare

Regular sessionNov 6 '26

PACBPacific Biosciences of California, Inc.

AAgilent Technologies, Inc.

2.30▼−5.47%

Price

173.96▲+1.27%

$792.6M

Mkt cap

$49.9B

Q3 FY26$41M

Revenue

$1.9BQ3 FY26

FY25$160M

Revenue

$6.9BFY25

PACB2.30▼−5.47%vsA173.96▲+1.27%Regular sessionNov 6 '26